SELLAS Life Sciences Group, Inc. SLS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -43.6%+23.3pp | -66.9%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 17.2×+6.5× | 10.7×+2.4× | 8.3×+3.4× | 4.9×+0.3× | 4.6×+2.9× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×-0.1× | |
| Per Share | ||||||
| Book value per share | $0.62-4.2% | $0.65+54.4% | $0.42+58.7% | $0.27-16.1% | $0.32+104% | |
| Valuation | ||||||
| Market capitalization | $759.63M+41.5% | $537.01M+167% | $201.22M+13.9% | $176.61M+80.0% | $98.11M+34.0% | |
| Price / book | 7.1×-0.5× | 7.6×+3.2× | 4.4×-2.3× | 6.8×+3.2× | 3.5×-4.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- SELLAS Life Sciences Group, Inc. (SLS) runs a 90.0% gross margin and a -4195.0% operating margin, with a -4130.1% net margin.
- Where do SELLAS Life Sciences Group, Inc.'s ratios come from?
- Every ratio is computed from SELLAS Life Sciences Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.